TAB Ribociclib 200mg, offered at Maharashtra Medical in Pune, plays a crucial role in the treatment of hormone receptor-positive, HER2-negative advanced breast cancer. This medication belongs to a class of drugs known as cyclin-dependent kinase 4/6 (CDK4/6) inhibitors, which work by blocking the activity of CDK4 and CDK6 proteins. These proteins play a key role in promoting the growth of cancer cells.
In hormone receptor-positive breast cancer, tumor growth is fueled by hormones like estrogen. Ribociclib works synergistically with hormone therapies, such as aromatase inhibitors or selective estrogen receptor modulators (SERMs), to inhibit the growth signaling pathways that cancer cells depend on for proliferation.
By inhibiting CDK4/6, Ribociclib helps to slow down the progression of advanced breast cancer, reducing the risk of disease worsening and extending the time until further treatment is needed. It is typically prescribed in combination with hormonal therapy to achieve maximum therapeutic benefit.
Patients receiving Ribociclib 200mg tablets should follow a treatment plan tailored by their healthcare provider, as dosage and administration are critical to optimizing efficacy and minimizing potential side effects. Regular monitoring during treatment is essential to assess response and manage any adverse reactions that may occur.
At Maharashtra Medical, we prioritize patient care by ensuring the availability of high-quality medications like Ribociclib sourced from reputable manufacturers. Our healthcare team provides comprehensive support and guidance, including information on medication usage, potential side effects, and the importance of adherence to treatment protocols.
Through advanced therapies like Ribociclib, Maharashtra Medical strives to improve treatment outcomes and quality of life for patients battling advanced breast cancer, offering hope and effective management options in their journey towards recovery.
Go to homepage
